| Patents for C07D 215 - Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems (27,676) |
|---|
| 09/30/2004 | US20040192719 Peptide deformylase inhibitors |
| 09/30/2004 | US20040192710 Such as trans-4-amino-3,4-dihydro-2,2-dimethyl-6-cyano-2H-benzopyran; for use as antiarrhythmic agents |
| 09/30/2004 | US20040192702 Heteroaryl alkyl piperazine derivatives |
| 09/30/2004 | US20040192700 Heating in solvent; controlling temperature; cooling; isolation; drying |
| 09/30/2004 | US20040192681 N-acylsulfonamide apoptosis promoters |
| 09/30/2004 | US20040191959 Electroluminescent iridium compounds with fluorinated phenylpryidines, phenylpyrimidines, and phenylquinolines and devices made with such compounds |
| 09/30/2004 | US20040188673 Electroluminescent iridium compounds with fluorinated phenylpryidines, phenylpyrimidines, and phenylquinolines and devices made with such compounds |
| 09/30/2004 | CA2517446A1 6-sulfonamide quinoline and chromene derivative as androgen receptor antagonists |
| 09/29/2004 | EP1462440A1 Naphthol derivative and charge control agent comprising the same |
| 09/29/2004 | EP1462108A1 Interferon g (g) production promoter |
| 09/29/2004 | EP1461319A1 Quinoline derivatives, synthesis method, and medicines containing said derivatives |
| 09/29/2004 | EP1461311A2 Urea derivatives as vr1-antagonists |
| 09/29/2004 | EP1198462B1 Process for preparing a 10,11-methanodibenzosuberane derivative |
| 09/29/2004 | EP1189881B1 Propanoic acid derivatives that inhibit the binding of integrins to their receptors |
| 09/29/2004 | EP1114033B1 4-carboxyamino-2-methyl-1,2,3,4-tetrahydroquinolines as cetp inhibitors |
| 09/29/2004 | CN1168704C Aryl and heteroaryl cyclopropyl oximidoether and its application as bactericide and pesticide |
| 09/28/2004 | US6797848 Anthracene derivative and organic electroluminescence device using the derivative |
| 09/28/2004 | US6797823 Quinoline derivatives and quinazoline derivatives |
| 09/28/2004 | US6797726 N-alkoxyalkyl-N,N-dialkylamine derivatives or salts thereof, and remedies for nerve degeneration diseases containing the same |
| 09/28/2004 | CA2224125C Pharmaceutical composition comprising a proteinase inhibitor and a monoglyceride |
| 09/23/2004 | WO2004080971A1 Tetrahydroquinoline derivatives useful as serine protease inhibitors |
| 09/23/2004 | WO2004080970A1 Novel bicyclic aromatic compounds, the production and use thereof in the form of drugs |
| 09/23/2004 | WO2004080969A1 Quinolinone / benzoxazinone derivatives and uses thereof |
| 09/23/2004 | WO2004080480A1 Pharmaceutical preparations comprising acid-stabilised insulin |
| 09/23/2004 | WO2004080462A1 c-Kit KINASE INHIBITOR |
| 09/23/2004 | WO2004080377A2 Kcnq channel modulating compounds and their pharmaceutical use |
| 09/23/2004 | WO2004072042A3 Quinoline derivative and their use for modulation of lxr activity |
| 09/23/2004 | WO2004072027A3 Chemical derivatives binding very specifically with g-quadruplex dna structures and use thereof as a specific anti-cancer agent |
| 09/23/2004 | US20040186154 treating or preventing a hypercholesterolemia-related or an inflammation-related condition ; apical sodium co-dependent bile acid transport inhibitor and an amount of a cyclooxygenase-2 (COX-2) selective inhibitor or its prodrug; kits |
| 09/23/2004 | US20040186146 E.g., R-N-2-[4-(pyrrolidin-1'-yl)methylphenyl]propionyl-methanesulfonamide; inhibition of chemotaxis of neutrophils induced by interleukin-8; antiinflammatory agents; psoriasis, ulcerative cholitis, glomerular nephritis, acute respiratory insufficiency, idiopathic fibrosis, and rheumatoid arthritis |
| 09/23/2004 | US20040186145 Sulfur substituted sulfonylaminocarboxylic acid N-arylamides, their preparation, their use and pharmaceutical preparations comprising them |
| 09/23/2004 | US20040186133 preferably antagonists used in the therapeutic and/or preventive treatment of disfunctions of the heart, kidney, respiratory system, central nervous system |
| 09/23/2004 | US20040186132 Steroid receptor modulator compounds and methods |
| 09/23/2004 | US20040186123 such as 2[(Benzyloxy)methyl]-8-methyl-2,3-dihydro[1,4]dioxino[2,3-f]quinoline; serotonin receptor antagonists for treatment of depression, obsessive compulsive disorders, panic disorder, generalized anxiety disorder, social anxiety disorders, sexual dysfunction, and eating disorders |
| 09/23/2004 | US20040186102 such as {4-Chloro-3-[2-(3,4-dihydro-1H-isoquinolin-2-yl)ethoxy]phenyl}-(2-methylquinolin-4-yl)amine for treatment of cardiovascular disorders, kidney disorders, pain and inflammation |
| 09/23/2004 | US20040186092 Tertiary carbocyclic amides such as 1-(3-Piperazin-1-yl-benzyl)-3,4-dihydro-1H-quinolin-2-one, used as serotonin receptor antagonists for prophylaxis of nervous system disorders and gastrointestinal disorders |
| 09/23/2004 | DE10310278A1 New N-(benzazinyl)-(hetero)aralkylamine derivatives, are inhibitors of factor Xa and/or related serine proteases, useful e.g. as antithrombotic agents and intermediates |
| 09/23/2004 | CA2518403A1 Quinolinone/benzoxazinone derivatives and uses thereof |
| 09/22/2004 | EP1458719A1 Pyridoquinoxaline antivirals |
| 09/22/2004 | EP1458718A1 Quinolinones as prostaglandin receptor ligands |
| 09/22/2004 | EP1458676A2 Compounds for the treatment of inflammatory disorders |
| 09/22/2004 | EP1458375A2 Compositions for decreasing activity of hormone-sensitive lipase |
| 09/22/2004 | EP1458374A2 Compounds and uses thereof for decreasing activity of hormone-sensitive lipase |
| 09/22/2004 | EP1100503B1 Non-imidazole alkylamines as histamine h 3?-receptor ligands and their therapeutic applications |
| 09/22/2004 | CN1531531A Novel arylsusfonamide compounds for treatment of obesity, type II diabetes and CNS-disorders |
| 09/22/2004 | CN1531528A Dibenzocycloheptene compound |
| 09/22/2004 | CN1530372A Inhibitor of hecterocyclic oxoaminoethylol aminosulfonic amine reverse transcripted virus protenase |
| 09/22/2004 | CN1167673C Fluorovinyloxyacetamides, process for preparing the same and herbicidal composition comprising the same |
| 09/21/2004 | US6794392 Cell differentiation inducer |
| 09/21/2004 | US6794389 Quinazoline derivatives and drugs |
| 09/21/2004 | US6794372 Nitrate salts of antimicrobial agents |
| 09/21/2004 | CA2155843C Novel urea derivatives, their preparation and use |
| 09/16/2004 | WO2004078988A1 Process for production of aromatic diols |
| 09/16/2004 | WO2004078731A1 Quinoline-carboxylic acids and the derivatives thereof, a focused library |
| 09/16/2004 | WO2004078730A2 Method for producing optically active amines |
| 09/16/2004 | WO2004078119A2 Substituted thiophenes with antibacterial activity |
| 09/16/2004 | WO2004078114A2 Pyridine, pyrimidine, quinoline, quinazoline, and naphthalene urotensin-ii receptor antagonists. |
| 09/16/2004 | WO2004064972A9 Capture compounds, collections thereof and methods for analyzing the proteome and complex compositions |
| 09/16/2004 | WO2004056322A3 Antibiotics containing borinic acid complexes and methods of use |
| 09/16/2004 | US20040180964 anti-obestic activity; Neuropeptide Y antagonist |
| 09/16/2004 | US20040180947 Sulfonamide compounds and pharmaceutical use thereof |
| 09/16/2004 | US20040180939 Acetyl 2-hydroxy-1, 3-diaminoalkanes |
| 09/16/2004 | US20040180910 Heterocycle carboxamides as antiviral agents |
| 09/16/2004 | US20040180902 3-Substituted quinoline-4-carboxamide derivatives as nk-3 and nk-2 receptor antagonists |
| 09/16/2004 | US20040180884 Dibenzocycloheptene compound |
| 09/16/2004 | US20040180829 Compounds and methods for regulating bacterial growth and pathogenesis |
| 09/16/2004 | CA2517523A1 Substituted thiophenes with antibacterial activity |
| 09/16/2004 | CA2517166A1 Pyridine, pyrimidine, quinoline, quinazoline, and naphthalene urotensin-ii receptor antagonists |
| 09/15/2004 | EP1456213A1 Rare earth metal compounds and mixtures of these |
| 09/15/2004 | EP1456205A1 Imidazoquinoline derivatives |
| 09/15/2004 | EP1456204A1 Triazolo-quinolin derivatives useful as adenosine receptor ligands |
| 09/15/2004 | EP1456203A1 Ethylene diamine derivatives and their use as orexin-receptor antagonists |
| 09/15/2004 | EP1455934A1 Method for isomerizing allyl alcohols |
| 09/15/2004 | EP1455777A1 Glyt1 transporter inhibitors and uses thereof in treatment of neurological and neuropsychiatric disorders |
| 09/15/2004 | EP1274686A4 Process for preparing 2-(4-chlorobenzolamino) -3- 2(1h) -quinolinon-4-yl]proprionic acid |
| 09/15/2004 | EP1001774B1 Use of phospholamban inhibitors for increasing coronary flow |
| 09/15/2004 | CN1529701A Tocopherols, tocotrienols, other chroman and side chain dervative and uses thereof |
| 09/15/2004 | CN1529696A Method for preparing CETP inhibitors |
| 09/15/2004 | CN1529695A Anthranilic acid amides with heteroarylsulfonyl side chain, method for production thereof, use thereof as medicament or diagnostic agent and phamaceutical preparations containing same |
| 09/15/2004 | CN1529601A 四氢喹啉衍生物 Tetrahydroquinoline derivative |
| 09/15/2004 | CN1528748A Polysubstituted quinazine derivative funcional material, and preparing method and thereof |
| 09/15/2004 | CN1166645C Bicyclic heterocyles, medicaments contg. these compounds, their use and methods for prodn. thereof |
| 09/15/2004 | CN1166639C Antimalarial quinolin derivatives, its preparation and use |
| 09/14/2004 | US6790858 Quinoline, isoquinoline and phthalazine derivatives as antagonists of the gonadotropin-releasing hormone |
| 09/10/2004 | WO2004076422A1 Process for preparing 5-‘(r)-2-(5,6-diethyl-indian-2-ylamino)-1-hydroxy-ethyl!-8-hydroxy-(1h)-quinolin-2-one salt, useful as an adrenoceptor agonist |
| 09/10/2004 | WO2004076386A2 Carbamic acid compounds comprising a bicyclic heteroaryl group as hdac inhibitors |
| 09/10/2004 | WO2004075898A1 4-[(2,4-dichloro-5-methoxyphenyl)amino]-6-alkoxy-3-quinolinecarbonitriles for the treatment of ischemic injury |
| 09/10/2004 | WO2004075858A2 Flavone acetic acid analogs and methods of use thereof |
| 09/10/2004 | WO2004056755A3 Compounds for the inhibition of non-proteolytic enzymes |
| 09/10/2004 | WO2004034985A3 Chemical compounds |
| 09/10/2004 | WO2004022523A3 1, 3-diamino-2-hydroxypropane prodrug derivatives |
| 09/10/2004 | CA2516842A1 Hydroxamic acid compounds comprising a bicylic heteroaryl group as hdac inhibitors |
| 09/10/2004 | CA2516418A1 4-[(2,4-dichloro-5-methoxyphenyl)amino]-6-alkoxy-3-quinolinecarbonitriles for the treatment of ischemic injury |
| 09/09/2004 | US20040176615 Forming calcium salt from ester |
| 09/09/2004 | US20040176604 such as (methyl-sulfonyl)methyl bromo-quinoline by treatment of dibromomethyl bromo-quinoline with sodium methanesulfinate in solvent; chemical intermediates in production of phosphodiesterase inhibitors |
| 09/09/2004 | US20040176602 3-Cyanoquinolines,3-cyano-1,6-naphthyridines, and 3-cyano-1,7-naphthyridines as protein kinase inhibitors |
| 09/09/2004 | US20040176462 NPY Y5 antagonist |
| 09/09/2004 | US20040176461 Sulfonyl-amino or carbonyl-amino derivatives; osteoporosis bone disorders; therapeutic drug or kits including anti-resorptive agents, anabolic agents; |
| 09/09/2004 | US20040176409 treating or preventing a metabolic disorder or an inflammatory condition; modulate the PPAR gamma receptor; diagnosis and treatment of: type II diabetes, hypercholesterolemia, and inflammatory disorders |
| 09/08/2004 | EP1454898A1 Novel phenylalanine derivative |